BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33835973)

  • 21. Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer.
    Zhou W; Lv R; Qi W; Wu D; Xu Y; Liu W; Mou Y; Wang L
    PLoS One; 2014; 9(1):e87409. PubMed ID: 24489910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
    Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
    Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.
    Yao J; Cai HH; Wei JS; An Y; Ji ZL; Lu ZP; Wu JL; Chen P; Jiang KR; Dai CC; Qian ZY; Xu ZK; Miao Y
    Oncol Rep; 2010 May; 23(5):1375-82. PubMed ID: 20372854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
    Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
    J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer.
    Bao B; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Aboukameel A; Mohammad R; Van Buren E; Azmi AS; Sarkar FH
    Stem Cells Dev; 2014 Aug; 23(16):1947-58. PubMed ID: 24734907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer.
    Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
    Cancer Lett; 2019 Sep; 459():204-215. PubMed ID: 31199988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.
    Block KM; Hanke NT; Maine EA; Baker AF
    Pancreas; 2012 Jul; 41(5):773-81. PubMed ID: 22273698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells.
    Xu XT; Chen J; Ren X; Ma YR; Wang X; Ma YY; Zhao DG; Zhou RP; Zhang K; Goodin S; Li DL; Zheng X
    Eur J Pharmacol; 2021 Feb; 893():173840. PubMed ID: 33359649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
    Zhang Y; Zoltan M; Riquelme E; Xu H; Sahin I; Castro-Pando S; Montiel MF; Chang K; Jiang Z; Ling J; Gupta S; Horne W; Pruski M; Wang H; Sun SC; Lozano G; Chiao P; Maitra A; Leach SD; Kolls JK; Vilar E; Wang TC; Bailey JM; McAllister F
    Gastroenterology; 2018 Jul; 155(1):210-223.e3. PubMed ID: 29604293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
    Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
    PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation.
    Liu X; Xie P; Hao N; Zhang M; Liu Y; Liu P; Semenza GL; He J; Zhang H
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34706936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population.
    Watanabe Y; Yoshimura K; Yoshikawa K; Tsunedomi R; Shindo Y; Matsukuma S; Maeda N; Kanekiyo S; Suzuki N; Kuramasu A; Sonoda K; Tamada K; Kobayashi S; Saya H; Hazama S; Oka M
    Int J Oncol; 2014 Nov; 45(5):1857-66. PubMed ID: 25118635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness.
    Zhang L; Shi H; Chen H; Gong A; Liu Y; Song L; Xu X; You T; Fan X; Wang D; Cheng F; Zhu H
    Cell Death Dis; 2019 Sep; 10(10):724. PubMed ID: 31558702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.
    Li L; Hao X; Qin J; Tang W; He F; Smith A; Zhang M; Simeone DM; Qiao XT; Chen ZN; Lawrence TS; Xu L
    Gastroenterology; 2014 Apr; 146(4):1108-18. PubMed ID: 24397969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
    Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
    Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
    Park SH; Sung JH; Chung N
    Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.
    Chai X; Chu H; Yang X; Meng Y; Shi P; Gou S
    Sci Rep; 2015 Sep; 5():14404. PubMed ID: 26391180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
    Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.